🚀CELLULAR DYNAMICS INTERNATIONAL SENDS HUMAN IPSC-DERIVED CARDIOMYOCYTES TO INTERNATIONAL SPACE STATION ON NASA RESUPPLY MISSION

By Sattelite, Space

🚀CELLULAR DYNAMICS INTERNATIONAL SENDS HUMAN IPSC-DERIVED CARDIOMYOCYTES TO INTERNATIONAL SPACE STATION ON NASA RESUPPLY MISSION.

MADISON, Wis., Dec. 27, 2017— Cellular Dynamics International (CDI), a FUJIFILM company, the leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSC-cells, announced that its iCell® Cardiomyocytes were launched into space via SpaceX’s 13th commercial resupply services mission to the International Space Station on Dec.15, 2017.

The purpose of the scientific research project utilizing CDI’s iCell Cardiomyocytes in space is to validate the function of NASA’s new Bioculture System for automated cell culture on the International Space Station and to study human cardiac cell function in microgravity.

Press Center | Fujifilm USA

http://www.fujifilmusa.com/press/news/display_news?newsID=881329

More from tokioX :

  1. METI: Tellus Offers Free Land, Sea, Air Data-Launched in February, New Business
  2. JAXA: “Hayabusa 2” moment of landing – First public presentation of video
  3. Branson’s Virgin Galactic reaches edge of space
  4. NASA fixes Hubble gyroscope by turning it off and on again
  5. The first large-scale collaborative project in Japan and Europe, the International Mercury Exploration Plan “BepiColombo” will be launched.
  6. Hayabusa2 probe landing delayed due to rugged asteroid surface
  7. JST: “Hayabusa 2” arrives on asteroid “Ryuguu” 27th